← Back to Search

Other

Epigallocatechin gallate for Dietary Preferences

N/A
Waitlist Available
Led By Cordelia Running, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months per sub-study (intervention type)
Awards & highlights

Study Summary

This study is evaluating whether exposure to flavors alters the perception of the flavor by changing an individual's salivary protein profile.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months per sub-study (intervention type)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months per sub-study (intervention type) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Flavor intensity ratings
Flavor rankings
Salivary proteins

Trial Design

3Treatment groups
Experimental Treatment
Group I: Linoleic acidExperimental Treatment2 Interventions
Linoleic acid emulsion will be provided to participants to rinse with daily for two weeks. A control solution will be provided for two weeks as well. Order will be counterbalanced across participants and groups.
Group II: Epigallocatechin gallateExperimental Treatment2 Interventions
Epigallocatechin gallate solutions will be provided to participants to rinse with daily for two weeks. A control solution will be provided for two weeks as well. Order will be counterbalanced across participants and groups.
Group III: CapsaicinExperimental Treatment2 Interventions
Capsaicin solutions will be provided to participants to rinse with daily for two weeks. A control solution will be provided for two weeks as well. Order will be counterbalanced across participants and groups.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,698 Previous Clinical Trials
7,492,467 Total Patients Enrolled
Purdue UniversityLead Sponsor
224 Previous Clinical Trials
72,732 Total Patients Enrolled
Cordelia Running, PhDPrincipal InvestigatorPurdue University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025